Ethical investing: how ethical is your ESG fund?

There’s no doubt that environmental and other issues can have a huge impact on share prices – 2020 has proven that beyond doubt. But how can investors ensure they are backing the right ESG funds?

So pervasive has concern about environmental, social and governance (ESG) issues become that it is hard to find a fund presentation without a slide on it or an annual report without a section explaining how seriously the manager takes the issue. What is less easy to find out is whether what lies behind this is just a box-ticking exercise; the use of an off-the-peg service; or some serious thought about the principles. Yet 2020 has shown how important the issue can be. 

The 80% drop in the oil price earlier this year has hit oil majors BP and Shell hard, forcing them to cut their dividends. Though the oil price has now recovered to be “only” 30% down, both companies’ share prices have fallen by roughly half. Meanwhile, those investors who avoided fossil fuel companies for renewable energy generators have continued to collect dividends on unchanged share prices, despite falling electricity prices and the absence of subsidies on new projects.

Meanwhile, revelations in The Sunday Times in July about terrible working conditions and illegal wages at garment factories in Leicester saw the share price of fashion retailer Boohoo halved. Until then, investors had enjoyed the benefit to the share price of high margins (perhaps as a result of the low wages), but the benefit of profit maximisation has proved illusory, even though a substantial chunk of the fall has since been recovered. This displays the potential advantages of focusing on the “S” and “G” parts of ESG – although it’s also worth noting that several ESG funds were caught out on Boohoo, only selling after the revelations.

Fund managers need to think for themselves

So investors need to think for themselves – but it isn’t easy. Laura Foll, a fund manager at Janus Henderson, notes that “on the system we use, [pharmaceuticals group] AstraZeneca has a worse score than [tobacco makers] BAT and Imperial because the system focuses not on what companies do, but how they do it. We need to understand the reasons behind the scores that are coming out and decide if we think they are correct.” 

Furthermore, coverage of smaller companies is poor and judgements highly subjective (see below). Is nuclear energy an environmental paragon or pariah? Has online betting turned gambling into a toxic business outside regulatory control? How do you draw the line between arms manufacturers and firms, such as Rolls-Royce, that operate more loosely in the defence sector? Governance is particularly tricky to judge. Foll says that, using the Henderson system, Rolls-Royce scores poorly due to the government’s “golden share”, on the grounds that not all shareholders have equal rights – yet this could be a positive in some cases. Non-voting shares were once common in the stockmarket but have almost disappeared; for one survivor in the investment trust sector, Hansa Trust, the non-voting shares are actually priced higher than the voting ones. In the US, the tech giants have often restricted voting rights for the public shares so that the founder shareholders could retain control, but few complain or boycott the shares. 

The risks of taking the ethical stance

And of course, sometimes taking the moral high road simply won’t pay off – at least, not at first. Asian investors with high ESG scruples, such as Stewart Investors, are highly wary of Chinese companies due to their reputation for poor corporate governance, but Stewart Investors’ performance has suffered as a result. 

There’s also the risk that consensus views on ESG issues could change. The replacement of fossil fuels with renewables is an unstoppable trend – resource wealth has not generally been a source of political stability and wealth; extracting energy from the weather is surely preferable. But today’s focus on carbon footprint, for example, may come to be seen as excessive. 

Investment managers who are thinking deeply about ESG include Stewart Investors (Pacific Assets, Scottish Oriental and Scotgems) and Impax (Impax Environmental Markets). A number of mainly younger managers, such as Foll, go much further than simply using their company’s systems and are well worth following. Unfortunately, though, private investors have to do their own ESG research to ensure their investments comply with what are often personal views. Equally though, those concerned solely about returns need to remember that ESG is having an increasing impact on share prices – regardless of their own views on the issues involved.

No simple screening solution

As the troubles at Boohoo suggest, there is no easy, purely quantitative way to screen companies for ESG factors. As Joseph Mariathasan, a director of ESG consultants GIST, puts it: “You can’t simply add together separate scores for E, S and G.”

 The variations between systems make this clear. For example, the GIST team notes that the ESG scores of Japanese stocks show no correlation between MSCI and FTSE. And while electric car manufacturer  Tesla scores highly with MSCI, it does badly with FTSE. GIST believes it is possible to devise a reliable system, but describes its process as “E, S and some G”. 

In short, as Kate Allen of the Financial Times wrote recently, “there are lies, damned lies and ESG rating methodologies”.  And as an investor, that means you need to be prepared to do more research yourself.

Recommended

Imperial Brands has an 8.3% yield – but what’s the catch?
Share tips

Imperial Brands has an 8.3% yield – but what’s the catch?

Tobacco company Imperial Brands boasts an impressive dividend yield, and the shares look cheap. But investors should beware, says Rupert Hargreaves. H…
20 May 2022
What's behind Sri Lanka’s crippling debt crisis?
Emerging markets

What's behind Sri Lanka’s crippling debt crisis?

Sri Lanka has been hit by a triple whammy of economic shocks and has gone to the IMF for a bailout. It may just be the first domino to fall in a globa…
20 May 2022
Investing in drugmakers: uncommon profits from curing rare diseases
Share tips

Investing in drugmakers: uncommon profits from curing rare diseases

Treatments for medical conditions with only a small number of sufferers can still be very attractive for pharmaceutical companies and investors becaus…
20 May 2022
Share tips of the week – 20 May
Share tips

Share tips of the week – 20 May

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
20 May 2022

Most Popular

Barry Norris: we’re already in the 1970s. Here’s how to invest
Investment strategy

Barry Norris: we’re already in the 1970s. Here’s how to invest

Merryn talks to Barry Norris of Argonaut capital about the parallels between now and the 1970s; the transition to “green” energy; and the one sector w…
19 May 2022
The ten highest dividend yields in the FTSE 100
Income investing

The ten highest dividend yields in the FTSE 100

Rupert Hargreaves looks at the FTSE 100’s top yielding stocks for income investors to consider.
18 May 2022
Share tips of the week – 20 May
Share tips

Share tips of the week – 20 May

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
20 May 2022